1-6 of 6
Giuseppa Careddu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Martina Di Trani, Ettore Rizzo, Silvia Locatelli, PhD, Fabrizio Marino, MD, Vanessa Cristaldi, PhD, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Federica De Paoli, PhD, Giuseppa Careddu, Marcello Rodari, MD, Margarita Kirienko, MD, Eleonora Calabretta, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesca Ricci, MD, Arturo Chiti, MD, Armando Santoro, Stefan Hohaus, MD, Davide Rossi, MD PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 131.
https://doi.org/10.1182/blood-2019-131096
Published: 2019
Journal Articles

The Novel Calcium Release-Activated Calcium (CRAC) Channel Inhibitor RP4010 Exerts Potent Antitumor Effects in NOD/SCID/IL2Rg -/- Mice with Diffuse Large B Cell Lymphoma (DLBCL) Cell Line Xenografts

Silvia Laura Locatelli, PhD, Giuseppa Careddu, Massimo Magagnoli, MD, Martina di Trani, Lucia Morello, MD, Srikant Viswanadha, PhD, Swaroop Kumar VS Vakkalanka, PhD, Luca Castagna, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4101.
https://doi.org/10.1182/blood.V130.Suppl_1.4101.4101
Published: 2017
Journal Articles

RNA Sequencing Reveals Mechanisms Underlying Modulation of Hodgkin Lymphoma Cells and Tumor Microenvironment By the PI3K δ/γ Inhibitor, RP6530

Silvia Laura Locatelli, PhD, Francesca Maria Consonni, PhD, Giuseppa Careddu, Simone Serio, Srikant Viswanadha, PhD, Swaroop Kumar VS Vakkalanka, PhD, Lucia Morello, MD, Massimo Magagnoli, MD, Luca Castagna, MD, Armando Santoro, MD, Antonio Sica, PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2476.
https://doi.org/10.1182/blood.V130.Suppl_1.2476.2476
Published: 2017
Journal Articles

Treatment of Hodgkin Lymphoma Xenografts with the Novel PI3K δ/γ Inhibitor RP6530 Suppresses M2 Macrophage Polarization and Results in Potent Antitumor and Antiangiogenic Effects

Silvia Laura Locatelli, PhD, Francesca Maria Consonni, Giuseppa Careddu, Simone Serio, Srikant Viswanadha, PhD, Swaroop Vakkalanka, PhD, Luca Castagna, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2016) 128 (22): 45.
https://doi.org/10.1182/blood.V128.22.45.45
Published: 2016
Journal Articles

Synergistic Induction of Cell Death in Hodgkin Lymphoma Cells By the Novel PI3K Inhibitor RP6530 Combined with Brentuximab Vedotin (SGN-35) through Inhibition of Tumor Angiogenesis

Silvia Laura Locatelli, PhD, Giuseppa Careddu, Armando Chierchia, Srikant Viswanadha, PhD, Swaroop Vakkalanka, PhD, Luca Castagna, Armando Santoro, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2015) 126 (23): 1561.
https://doi.org/10.1182/blood.V126.23.1561.1561
Published: 2015
Journal Articles

Upregulation of Cereblon Expression By the DNA Methyltransferase Inhibitor Azacytidine Strongly Enhances Lenalidomide Cytotoxicity in Germinal Center B-Cell-like (GCB) and Activated B-Cell-like (ABC) Diffuse Large B-Cell Lymphoma (DLBCL)

Silvia L Locatelli, PhD, Roberto Papait, PhD, Giuseppa Careddu, Ada Koschorke, Giuliano G Stirparo, Monica Balzarotti, MD, Luca Castagna, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2014) 124 (21): 2253.
https://doi.org/10.1182/blood.V124.21.2253.2253
Published: 2014